HMGB1 and Parkinson disease: This study also showed that paeonol and miR-339-5p may be promising therapeutic agents for the treatment of various inflammatory diseases such as Parkinson’s disease, organ failure, cancer, and especially sepsis, while HMGB1 and IKK-β may be promising therapeutic targets.